Dry extract BNO 1011 inhibits human influenza a replication and neuraminidase activity in oseltamivir-resistant and -sensitive viral strains
Main Authors: | Seifert, Stephanie, Wosikowski, Katja, Haunschild, Jutta |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716544/ |
Similar Items
-
Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis
by: Jund, Rainer, et al.
Published: (2015) -
Molecular Dynamics Studies
Of The Effects Of Neuraminidase
Mutation On Oseltamivir Resistance
by: Muhammad Yusuf, Muhammad Yusuf
Published: (2015) -
Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
by: Tran-To Su, Chinh, et al.
Published: (2013) -
A Computational-Experimental Approach Identifies Mutations That Enhance Surface Expression of an Oseltamivir-Resistant Influenza Neuraminidase
by: Bloom, Jesse D., et al.
Published: (2011) -
A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses
by: Escuret, Vanessa, et al.
Published: (2014)